Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

BluePearl Pet Hospital Finds Alarming Increase in Parvovirus Cases Amid COVID-19

In 2020, positive parvovirus cases and hospitalizations increased by 70% in BluePearl Pet Hospitals.


News provided by

BluePearl Specialty + Emergency Pet Hospital

Jul 06, 2020, 15:05 ET

Share this article

Share toX

Share this article

Share toX


TAMPA, Fla., July 6, 2020 /PRNewswire-PRWeb/ -- BluePearl Specialty and Emergency Pet Hospital has observed an alarming increase in the number of parvovirus cases and hospitalizations during the COVID-19 pandemic. Analysis of data from BluePearl's more than 90 pet hospitals showed a 70% increase in the number of parvovirus cases relative to ER cases in 2020 as compared to the same time periods in the past five years (2015 to 2019).

Parvovirus, or parvo, is a highly contagious, potentially deadly disease that attacks the gastrointestinal tracts of infected canines. While puppies are most at risk for contracting parvo, any unvaccinated or partially vaccinated dog can contract the disease through dog-to-dog contact and contact with contaminated stool, environments, or people. If left untreated, most parvo deaths occur within 48 to 72 hours. However, survival rates can approach 90% with proper treatment.

"As invaluable sources of emotional support as well as sentinels and potential vectors of infectious disease, it is vital pets receive all preventative care vaccines, and owners adhere to the timing requirements of those vaccines," remarked Dr. James Barr, Chief Medical Officer.

Post this

"We are in the very early stages of analyzing this data; looking for possible causes of the increase and determining what the implications are for this and other preventable companion animal diseases," remarked James Barr, DVM, DACVECC, Chief Medical Officer, BluePearl Pet Hospital. "Parvo outbreaks pose a serious threat to our canine friends but skipping routine vaccinations could also put human health at risk through the possibility of rabies exposure. As invaluable sources of emotional support as well as sentinels and potential vectors of infectious disease, it is vital pets receive all preventative care vaccines, and owners adhere to the timing requirements of those vaccines."

Amid the COVID-19 outbreak, many people turned to animals for companionship. This resulted in significant fostering and adoption of shelter animals. Some of these shelter animals may have been released without completion of their vaccination series. Stay at home orders also prompted a trend in people spending more time outdoors, which could have increased environmental exposure (i.e. dog parks). Other possible causes for the uptick include disruptions in the timing of or prevention of puppies receiving full vaccine series, resulting in incomplete immunity, and financial hardships, such as job loss, preventing or delaying owners from seeking routine vaccinations.

"If the U.S. continues to see COVID-19 cases increase or a second wave, this may exacerbate these trends and further harm our pets," explained Lenore Bacek, DVM, MS, DACVECC, Clinical Programs Manager, BluePearl Pet Hospital. "To prevent further increase, and to ensure this does not happen again, veterinary hospitals and related businesses must continue to be recognized as essential services. Owners must also be vigilant not to bring their dogs or puppies to dog parks or other high traffic areas until fully vaccinated. As we delve deeper into this data, we hope to better understand the complexities of this parvovirus outbreak, as well as shine light on the value veterinary medicine brings to public health."

While dogs and puppies may begin showing signs of parvovirus between three to ten days after exposure, they are often contagious before visible symptoms. If you suspect your pet has parvovirus, immediately isolate your pet and contact your primary care veterinarian.

About BluePearl Specialty and Emergency Pet Hospital
Founded in 1996, BluePearl is one of the largest specialty and emergency veterinary practices in the U.S. today. BluePearl has more than 90 hospitals in 26 states that together employ 5,900+ Associates, including 1,160+ veterinarians, 1,650+ veterinary technicians, and 3,000+ other professionals. Each year, our compassionate teams provide high-quality care for over one million pets and their families. BluePearl clinicians also participate in clinical studies to discover new treatments and procedures that improve pet health. As part of the Mars Veterinary Health family of brands, BluePearl is committed to its purpose—A BETTER WORLD FOR PETS®—because pets make a better world for us. Learn more at https://bluepearlvet.com/.

SOURCE BluePearl Specialty + Emergency Pet Hospital

Related Links

http://bluepearlvet.com/

Modal title

Parvovirus Fact Sheet
View PDF
Parvovirus Fact Sheet
Parvovirus Fact Sheet

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.